A Comparison of Antiarrhythmic Drug Therapy and Radio Frequency Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation

PHASE4CompletedINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

August 1, 2003

Primary Completion Date

June 1, 2006

Study Completion Date

June 1, 2006

Conditions
Paroxysmal Atrial Fibrillation
Interventions
DEVICE

Radiofrequency ablation, antiarrhythmic drugs

Patients receive either treatment.

DRUG

Amiodarone, flecainide, propafenone, quinidine, dofetilide, sotalol, cibenzoline, beta blocking and calcium channel blocking agents and antiarrhythmic drugs

Amiodarone will be taken at 600 mg per day for 21 days (as a loading dose) followed by 1.4g per week or 200mg per day. The daily dose may be increased to 300mg or 2.1g per week.

DEVICE

ThermoCool Radiofrequency Catheter

Patient is ablated once, repeat ablation if paroxysmal atrial fibrillation reoccurs.

Trial Locations (6)

12111

Hopital Cantonal de Geneve, Geneva

35294

University of Alabama, Birmingham, Birmingham

43214

Mid-Ohio Cardiology, Columbus

75010

Hopital Lariboisiere, Paris

02114

Massachusetts General Hospital, Boston

Unknown

Hôpital Haut Lèvêque, Pessac

All Listed Sponsors
lead

Biosense Webster, Inc.

INDUSTRY

NCT00540787 - A Comparison of Antiarrhythmic Drug Therapy and Radio Frequency Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation | Biotech Hunter | Biotech Hunter